- Home
- LGVN vs PRPO Comparison
LGVN vs PRPO Comparison
Compare LGVN & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- PRPO
- Stock Information
- Founded
- LGVN 2014
- PRPO N/A
- Country
- LGVN United States
- PRPO United States
- Employees
- LGVN N/A
- PRPO N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- LGVN Health Care
- PRPO Industrials
- Exchange
- LGVN Nasdaq
- PRPO Nasdaq
- Market Cap
- LGVN 23.4M
- PRPO N/A
- IPO Year
- LGVN 2021
- PRPO N/A
- Fundamental
- Price
- LGVN $1.31
- PRPO $10.62
- Analyst Decision
- LGVN Strong Buy
- PRPO
- Analyst Count
- LGVN 3
- PRPO 0
- Target Price
- LGVN $8.67
- PRPO N/A
- AVG Volume (30 Days)
- LGVN 146.0K
- PRPO 8.2K
- Earning Date
- LGVN 08-13-2025
- PRPO 08-12-2025
- Dividend Yield
- LGVN N/A
- PRPO N/A
- EPS Growth
- LGVN N/A
- PRPO N/A
- EPS
- LGVN N/A
- PRPO N/A
- Revenue
- LGVN $2,225,000.00
- PRPO $20,029,000.00
- Revenue This Year
- LGVN N/A
- PRPO N/A
- Revenue Next Year
- LGVN $51.48
- PRPO N/A
- P/E Ratio
- LGVN N/A
- PRPO N/A
- Revenue Growth
- LGVN 127.50
- PRPO 26.67
- 52 Week Low
- LGVN $1.14
- PRPO $3.90
- 52 Week High
- LGVN $6.40
- PRPO $11.80
- Technical
- Relative Strength Index (RSI)
- LGVN 50.13
- PRPO 60.30
- Support Level
- LGVN $1.15
- PRPO $10.52
- Resistance Level
- LGVN $1.32
- PRPO $11.31
- Average True Range (ATR)
- LGVN 0.09
- PRPO 0.69
- MACD
- LGVN 0.01
- PRPO -0.15
- Stochastic Oscillator
- LGVN 45.31
- PRPO 73.72
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.